Stocks:
5,167
ETFs:
2,288
Exchanges:
11
Market Cap:
$62.23T
24h Vol:
$9.02B
Dominance:
MSFT:4.87%
Stocklytics Platform
Instrument logo  SBFM
Sunshine Biopharma
SBFM
76 / 100
High Growth
Penny Stock
$1.21arrow_drop_down15.97%-$0.23

Performance History

Stocklytics logo
Key Stats
Open$1.27
Prev. Close$1.44
EPS-19
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap1755341.00
PE Ratio-
LOWHIGH
Day Range1.23
1.28
52 Week Range1.23
140.00
Ratios
P/B Ratio0.38
Revenue-
Operating M. %-15.46%
Earnings$0.00
Earnings Growth %83.15%
EBITDA Margin %-19.24%
ROE %-21.04%
EPS-19

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

76vs 54. Market Avg.

All Score 76 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

SBFMMARKET
Value6940
Quality5740
Ownership717
Growth8047
Dividends-38
check_circle

Sunshine Biopharma's Price growth average in the last 3 years of 967.33% is great compared to market average of 5.25%. This indicates SBFM could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$738.38
24H (%)arrow_drop_up0.96%
24H ($)$7.04
MARKET CAP$695.32B
PRICE$491.05
24H (%)arrow_drop_down0.03%
24H ($)-$0.18
MARKET CAP$462.00B
PRICE$148.89
24H (%)arrow_drop_down0.15%
24H ($)-$0.23
MARKET CAP$359.34B
PRICE$127.62
24H (%)arrow_drop_up0.53%
24H ($)$0.68
MARKET CAP$321.54B

About Sunshine Biopharma (SBFM)

Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; SBFM-PL4, an anti-coronavirus treatment compound; and K1.1 mRNA molecules used as anti-cancer agents. It also offers Essential 9, an amino acids capsules; and Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name, as well as develops and markets other science-based nutritional supplements. Sunshine Biopharma, Inc. is based in Pointe-Claire, Canada.

Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Dr. Steve N. Slilaty Ph.D.
Headquarters
Pointe-Claire
Employees
46
Exchange
NASDAQ
add Sunshine Biopharma to watchlist

Keep an eye on Sunshine Biopharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Sunshine Biopharma's (SBFM) price per share?

The current price per share for Sunshine Biopharma (SBFM) is $1.26. The stock has seen a price change of -$0.16 recently, indicating a -11.11% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Sunshine Biopharma (SBFM)?

For Sunshine Biopharma (SBFM), the 52-week high is $140, which is 10.84K% from the current price. The 52-week low is $1.23, the current price is 4.07% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Sunshine Biopharma (SBFM) a growth stock?

Sunshine Biopharma (SBFM) has shown an average price growth of 967.33% over the past three years. It has received a score of 99 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Sunshine Biopharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Sunshine Biopharma (SBFM) stock price performance year to date (YTD)?

As of the latest data, Sunshine Biopharma (SBFM) has a year-to-date price change of .

help
Is Sunshine Biopharma (SBFM) a profitable company?

Sunshine Biopharma (SBFM) has a net income of -$4.51M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 33.99% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -15.46% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $8.19M. Operating income is noted at -$4.79M. Furthermore, the EBITDA is -$4.64M.

help
What is the market capitalization of Sunshine Biopharma (SBFM)?

Sunshine Biopharma (SBFM) has a market capitalization of $1.76M. The average daily trading volume is 2.68M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.